Analysts’ Viewpoint on Global Defibrillator Market Scenario
The rising number of home care settings due to the coronavirus pandemic has led to a rise in demand for defibrillators and created alternative revenue streams for med-tech companies in the defibrillator market. Although implantable cardioverter-defibrillators are linked with advantages for patients who have suffered a heart failure, risks of these devices such as tearing of heart muscle and collapsed lung are affecting its adoption. Hence, med-tech companies in the defibrillator market and healthcare practitioners should increase awareness about consent forms & precautions for implantation to avoid adverse events in individuals and prevent unnecessary healthcare burdens. Companies in the defibrillator market should diversify their product portfolio in automated external defibrillators and wearable cardioverter-defibrillators to accurately analyze a person’s heart rhythm & deliver an electric shock to save the person from irregular heart function.
Defibrillators are medical devices that deliver an electric shock or pulse to the heart in order to restore normal heartbeat. These are used to prevent or treat arrhythmias, which are irregular heartbeats that are either too slow or too fast. AEDs (automated external defibrillators) are portable, life-saving devices used to treat people who have suffered sudden cardiac arrest, a medical condition in which the heart suddenly and unexpectedly stops beating.
Automated external defibrillators (AEDs), which are now widely available in public places, are used to save the lives of people who have suffered a cardiac arrest. In an emergency, even untrained bystanders can use these devices. Other defibrillators can help people who are at high risk of dying from a life-threatening arrhythmia. Implantable defibrillators were only recommended for cardiac arrest survivors. With upgrade of surgical techniques and advancement in technology, defibrillator implantation is now considered an outpatient procedure.
Thus, Increase in research funding, rise in government support, improvements in regulatory framework, technological advancements, and surge in prevalence of chronic diseases are projected to drive the global defibrillator market during the forecast period.
Cardiovascular diseases (CVDs) are the leading cause of death globally, claiming the lives of an estimated 17.9 million people every year. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other heart & blood vessel disorders are classified as CVDs. Heart attack and stroke account for more than four out of every five CVD deaths, with one-third of these deaths occurring before the age of 70. Sudden cardiac death is the leading cause of natural death in the U.S., accounting for around 325,000 adult deaths each year. Half of all heart disease deaths are caused by sudden cardiac death.
The growth of the global defibrillator market can be attributed to technological advancements in the field of defibrillators and defibrillator training and awareness programs. There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology, including improved patient monitoring to prevent unnecessary shocks, the introduction of quadripolar lead devices to improve device programming and therapy effectiveness, and the development of MRI-safe ICDs.
Abbott Laboratories received CE mark for its product "Gallant" in 2020. It is an ICD (implantable cardioverter defibrillator) that prevents sudden cardiac arrest. Additionally, rise in prevalence of cardiovascular diseases is expected to propel the global market.
Moreover, the introduction of new products by key players is expected to propel the global defibrillator market during the forecast period. For instance, the new HeartStart Intrepid monitor/defibrillator from Royal Philips is designed to assess and treat patients in medical emergencies in both pre-hospital and hospital settings. The HeartStart Intrepid monitor/defibrillator was designed by Philips to be portable, lightweight, and rugged for use by emergency medical services (EMS) and transport within hospitals.
Philips was also a pioneer in providing automated external defibrillator (AEDs) for use in airplanes and was the first to introduce an AED for pediatric use. Presently, Philips AEDs can be found on board major airlines, airports, major hotels, Fortune 100 companies, and professional sports teams' locker rooms across the world.
In terms of application, the global defibrillator market has been classified into advanced life support defibrillators (ALS), automated external defibrillator (AED), implantable cardioverter-defibrillator (ICD), and wearable cardiac defibrillator. The automated external defibrillator (AED) segment accounted for major market share in 2020. AEDs are portable devices used to help those experiencing sudden cardiac arrest. Automated external defibrillator is a medical device that can analyze the heart's rhythm and deliver an electrical shock or defibrillation to help the heart re-establish an effective rhythm.
Based on end-user, the global defibrillator market has been classified into hospitals, emergency care, home care, and others. The hospitals segment dominated the global defibrillator market in 2020, and the trend is expected to continue during the forecast period due to higher number of cardiac patients treated in hospitals and surgeries performed in hospital settings.
In hospitals, both ICDs and external defibrillators are increasingly being used to treat patients with sudden cardiac arrest and other conditions.
Automated external defibrillator (AEDs) in public places are occasionally prone to failure due to issues with the battery, software, or hardware. Failure to defibrillate can result in treatment delays or even death. A number of defibrillators have been recalled in the past few years due to technical errors in the device's operation, including shock delivery, electrical issues, and hardware configuration. In some cases, these flaws can result in poor product performance and even death of the patient.
In terms of region, the global defibrillator market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to be a highly lucrative market for defibrillators during the forecast period. Rise in prevalence of cardiac disease in the U.S. is a major factor driving the market in the region. Surge in installations of external defibrillator in hospitals as well as in public spaces and favorable regulations are likely to drive the defibrillator market in North America during the forecast period.
This report profiles major players in the global defibrillator market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global defibrillator market is quite competitive, with the top 10 players accounting for key share of the market and companies focusing on research & development to produce better pharmaceutical and vaccine products for existing diseases.
Leading players operating in the global defibrillator market are Medtronic, Stryker Corporation, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, Nihon Kohden, MicroPort, BIOTRONIK, CU Medical Systems, METsis Medikal, Mediana Co. Ltd., and Mindray Medical International Ltd., among others.
Key players in the global defibrillator market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global defibrillator market. A few growth strategies adopted by players operating in the global defibrillator market are:
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 7.2 Bn |
|
Market Forecast Value in 2028 |
US$ 16.3 Bn |
|
Growth Rate (CAGR) |
8.9% |
|
Forecast Period |
2022-2031 |
|
Historical Data Available for |
2017-2020 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global defibrillator market was valued at US$ 7.2 Bn in 2021.
The global defibrillator market is expected to surpass US$ 16.3 Bn by 2031.
The global defibrillator market is anticipated to record a CAGR of 8.9% from 2022 to 2031.
Increase in incidence of cardiac disease and risk of cardiac arrest is expected to drive the global defibrillator market.
North America is expected to be a potential revenue generator for vendors during the forecast period.
Prominent players in the global defibrillator market include Medtronic, Stryker Corporation, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, Nihon Kohden, MicroPort, BIOTRONIK, CU Medical Systems, METsis Medikal, Mediana Co. Ltd., and Mindray Medical International Ltd., among others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Defibrillator Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Defibrillator Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario, by Region/Globally
5.4. COVID-19 Pandemics Impact on Industry
6. Global Defibrillator Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Advanced Life Support Defibrillators (ALS)
6.3.2. Automated External Defibrillator (AED)
6.3.3. Implantable Cardioverter-defibrillator (ICD)
6.3.4. Wearable Cardiac Defibrillator
6.4. Market Attractiveness Analysis, by Type
7. Global Defibrillator Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Emergency Care
7.3.3. Home Care
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Defibrillator Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Defibrillator Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017–2031
9.2.1. Advanced Life Support Defibrillators (ALS)
9.2.2. Automated External Defibrillator (AED)
9.2.3. Implantable Cardioverter-defibrillator (ICD)
9.2.4. Wearable Cardiac Defibrillator
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Emergency Care
9.3.3. Home Care
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Defibrillator Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Advanced Life Support Defibrillators (ALS)
10.2.2. Automated External Defibrillator (AED)
10.2.3. Implantable Cardioverter-defibrillator (ICD)
10.2.4. Wearable Cardiac Defibrillator
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Emergency Care
10.3.3. Home Care
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Defibrillator Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Advanced Life Support Defibrillators (ALS)
11.2.2. Automated External Defibrillator (AED)
11.2.3. Implantable Cardioverter-defibrillator (ICD)
11.2.4. Wearable Cardiac Defibrillator
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Emergency Care
11.3.3. Home Care
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Defibrillator Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Advanced Life Support Defibrillators (ALS)
12.2.2. Automated External Defibrillator (AED)
12.2.3. Implantable Cardioverter-defibrillator (ICD)
12.2.4. Wearable Cardiac Defibrillator
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Emergency Care
12.3.3. Home Care
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Defibrillator Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Advanced Life Support Defibrillators (ALS)
13.2.2. Automated External Defibrillator (AED)
13.2.3. Implantable Cardioverter-defibrillator (ICD)
13.2.4. Wearable Cardiac Defibrillator
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Emergency Care
13.3.3. Home Care
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Stryker Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Koninklijke Philips N.V.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Asahi Kasei Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Boston Scientific Corporation
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Nihon Kohden
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. BIOTRONIK
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. METsis Medikal
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Mediana Co. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Analysis
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. Mindray Medical International Ltd.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Analysis
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Defibrillator Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Defibrillator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 05: North America Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 06: North America Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe Defibrillator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 09: Europe Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: Asia Pacific Defibrillator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Asia Pacific Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Defibrillator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Latin America Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Middle East & Africa Defibrillator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Defibrillator Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 18: Middle East & Africa Defibrillator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figure
Figure 01: Global Defibrillator Market Value Share Analysis, by Type, 2021 and 2028
Figure 02: Global Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 03: Global Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 04: Global Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Figure 05: North America Defibrillator Market Value (US$ Mn) Forecast, 2017–2031
Figure 06: North America Defibrillator Market Value Share Analysis, by Country, 2021 and 2028
Figure 07: North America Defibrillator Market Attractiveness Analysis, by Country, 2021–2028
Figure 08: North America Defibrillator Market Value Share Analysis, by Type, 2021 and 2028
Figure 09: North America Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 10: North America Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 11: North America Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Figure 12: Europe Defibrillator Market Value (US$ Mn) Forecast, 2017–2031
Figure 13: Europe Defibrillator Market Value Share Analysis, by Country/Sub-region, 2021 and 2028
Figure 14: Europe Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 15: Europe Defibrillator Market Value Share Analysis, by Type, 2021 and 2028
Figure 16: Europe Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 17: Europe Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 18: Europe Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Figure 19: Asia Pacific Defibrillator Market Value (US$ Mn) Forecast, 2017–2031
Figure 20: Asia Pacific Defibrillator Market Value Share Analysis, by Country/Sub-region, 2021 and 2028
Figure 21: Asia Pacific Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 22: Asia Pacific Defibrillator Market Value Share Analysis, by Type, 2021 and 2028
Figure 23: Asia Pacific Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 24: Asia Pacific Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 25: Asia Pacific Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Figure 26: Latin America Defibrillator Market Value Share Analysis, by Country/Sub-region, 2021 and 2028
Figure 27: Latin America Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 28: Latin America Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 29: Latin America Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 30: Latin America Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Figure 31: Middle East & Africa Defibrillator Market Value Share Analysis, by Country/Sub-region, 2021 and 2028
Figure 32: Middle East & Africa Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 33: Middle East & Africa Defibrillator Market Attractiveness Analysis, by Type, 2021–2028
Figure 34: Middle East & Africa Defibrillator Market Value Share Analysis, by End-user, 2021 and 2028
Figure 35: Middle East & Africa Defibrillator Market Attractiveness Analysis, by End-user, 2021–2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Defibrillators Market
